Editorial Team

Editor-in-Chief

  1. Glenda C Gobe, MSc, PhD, Centre for Kidney Disease Research, Translational Research Institute, School of Medicine, University of Queensland, Australia

Scientific Advisory Board

  1. Alexander O Vortmeyer, MD, PhD, IU Health Pathology Laboratory, 350 West 11th Street, Room 4034, Indianapolis, IN, United States
  2. Glenda C Gobe, MSc, PhD, Centre for Kidney Disease Research, Translational Research Institute, School of Medicine, University of Queensland, Australia
  3. Hemamali Samaratunga MBBS, LRCP MRCS, FRCPA, Aquesta Pathology, Toowong, Queensland, Australia
  4. Keng Lim Ng, MBBS, MS, FRCS, PhD, Department of Urology, Princess Alexandra Hospital, Queensland, Australia
  5. Rachel Giles, PhD, Dept. Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, Netherlands
  6. Tahseen Al-Saleem, MD, Fox Chase Cancer Center, USA, United States
  7. W. Marston Linehan, MD, Urologic Oncology Branch, National Cancer Institute, MD, United States

Editorial Board Members

  1. Yoshihide Ogawa, MD, PhD, Department of Urology, Towa Hospital, Japan, Japan
  2. Benjamin L Maughan, MD, Pharm D, Genitourinary Medical Oncology, Division of Oncology, University of Utah, United States
  3. Ulka Vaishampayan, MD, Department of Oncology, Wayne State University, Detroit, United States
  4. Haifeng Yang, PhD, Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University Philadelphia, United States
  5. Tien Hsu, PhD., Graduate Institute of Systems Biology and Bioinformatics, National Central University, Chungli,, Taiwan, Province of China
  6. Ayyappan K Rajasekaran, PhD, Therapy Architects, LLC, Wilmington, DE, United States
  7. Azad Hassan Abdul Razak, MBBS, FRCS, Department of Surgery, Faculty of Medicine, University of Malaya, Malaysia
  8. Brunolf Walther Lagerveld, MD, PhD, Department of Urology, Onze Lieve Vrouwe Gasthuis (OLVG), Amsterdam, Netherlands
  9. Camillo Porta, MD., Oncologia Medica, Fondazione I.R.C.C.S. Policlinico San Matteo, Pavia, Italy
  10. Charles L Cowey, MD, Baylor Sammons Cancer Center, US Oncology Research, TX, United States
  11. Daniel C Cho, MD, NYU Cancer Institute, New York, NY, United States
  12. David A Vesey, PhD, The University of Queensland, Australia
  13. Eric Jonasch, M.D., The University of Texas MD Anderson Cancer Center, Houston, TX, United States
  14. Fumitaka Koga, MD,PhD, Department of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Japan
  15. Guofei Zhou, PhD, Department of Pediatrics, University of Illinois at Chicago, IL, United States
  16. Hiroshi Kanno, Department of Neurosurgery, International University of Health and Welfare, Japan
  17. James Hsieh, M.D., Ph.D., Human Oncology & Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, NY, United States
  18. Jasneet Singh Bhullar MD, MS, Department of Surgery, University of Minnesota, Minneapolis - St.Paul. MN, United States
  19. Keng Lim Ng, MBBS, MS, FRCS, PhD, Department of Urology, Princess Alexandra Hospital, Queensland, Australia
  20. Ramaprasad Srinivasan, MD, PhD, National Cancer Institute, NIH, United States
  21. Roberto Pili, M.D., Robert Wallace Miller Professor of Oncology Director, Genitourinary Oncology Professor of Medicine, Urology, Pharmacology and Toxicology, Indiana University, School of Medicine – Simon Cancer Center, Indianapolis, IN 46202, United States
  22. Samy L Habib, MS, PhD, The University of Texas Health Science Center at San Antonio, Department of Cellular and Structural Biology, San Antonio, TX, United States